Atlas Trials

FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole

Clinical trial NCT00199134 · COMPLETED

Trial details

NCT number
NCT00199134
Sponsor
Jules Bordet Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2004-11-01
Primary completion
2014-12-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.